DFX Intelligence
Borrowers
90 borrower groups currently held, grade A and BWhat a borrower group isA borrower group is every spelling of one credit agreement's borrower across the BDCs that hold it (Icefall Parent, Icefall Topco and Icefall Bidco are one). Grade A and B groups are listed; a short one-word stem (grade C) is kept apart and never merged across filers. Principal is the sum of BDC pieces and is a lower bound.Principal and marks are the filers' figures at each BDC's latest quarter end, summed. Maturity is the filer's tagged date or the date written into the identifier; a BDC that tags neither leaves it unstated.
Industry as filed contains “Healthcare & Pharmaceuticals” (remove)
Start from
90 borrower groups
| Borrower | Sponsor | BDCs | Principal held | On cost | Spread | Next maturity | First seen |
|---|---|---|---|---|---|---|---|
| RevHealth Life sciences | Sponsor not establishedpossible: Windrose Health Investors, LLC (a company of this name is on the sponsor's portfolio page) | 1 | at least $4.5M | 74c | n/a | Jul 21, 2028 | Dec 31, 2022 |
| QuidelOrtho Corporation Life sciences | unattributed | 5 | at least $4.0M | 99c | n/a | Aug 20, 2032 | Sep 30, 2025 |
| Minds + Assembly Life sciences | unattributed | 1 | at least $4.0M | 102c | n/a | May 3, 2029 | Jun 30, 2023 |
| P••••••• O••• H••••• Life sciences | Sponsor not establishedpossible: I••••••• C•••••• P•••••••• L•• (a company of this name is on the sponsor's portfolio page) | 1 | at least $4.0M | 101c | n/a | Nov 16, 2028 | Dec 31, 2023 |
| P••••••• P••••••• Life sciences | unattributed | 3 | at least $3.8M | 100c | n/a | Feb 28, 2029 | Mar 31, 2024 |
| E••••• A••••• H•••••• I•• Life sciences | unattributed | 3 | at least $3.8M | 100c | n/a | Oct 31, 2032 | Jun 30, 2024 |
| S••••• S•••• Life sciences | unattributed | 2 | at least $3.6M | 102c | n/a | Mar 25, 2031 | Dec 31, 2024 |
| N•••••• Life sciences | unattributed | 2 | at least $3.4M | 106c | n/a | Aug 29, 2031 | Sep 30, 2024 |
| Q•• A•••• 4• P•• L•• Life sciences | unattributed | 2 | at least $3.2M | 99c | n/a | Feb 5, 2032 | Mar 31, 2026 |
| U••• F••• a•• A•••• S••••••••• Life sciences | unattributed | 1 | at least $3.0M | 99c | n/a | Sep 15, 2026 | Dec 31, 2023 |
| n•••••• Life sciences · grade B | unattributed | 1 | at least $2.6M | 32c | n/a | Dec 15, 2028 | Dec 31, 2022 |
| A•••••••• E•••••• Life sciences | unattributed | 1 | at least $2.4M | 66c | n/a | Jun 13, 2029 | Dec 31, 2022 |
| F•••••••• Life sciences | unattributed | 2 | at least $2.4M | 99c | n/a | Mar 30, 2029 | Sep 30, 2022 |
| W•••••• D••••• Life sciences | Sponsor not establishedpossible: C•••• S••••• C•••••• (a company of this name is on the sponsor's portfolio page) | 3 | at least $2.2M | 99c | n/a | Jan 30, 2032 | Dec 31, 2022 |
| W•••••• Life sciences | unattributed | 3 | at least $2.0M | 100c | n/a | Mar 10, 2028 | Dec 31, 2022 |
| S•••••• Life sciences | unattributed | 4 | at least $1.9M | 75c | n/a | Jul 18, 2031 | Dec 31, 2022 |
| U••••••• R••••••••• Life sciences | Sponsor not establishedpossible: R••••••••• C•••••• P••••••• (a company of this name is on the sponsor's portfolio page) | 1 | at least $1.9M | 94c | n/a | Nov 20, 2029 | Dec 31, 2022 |
| G••••• H••••• Life sciences | unattributed | 1 | at least $1.9M | 98c | n/a | Jul 3, 2028 | Dec 31, 2022 |
| B••• C•••• Life sciences | unattributed | 1 | at least $1.7M | 100c | n/a | Jan 21, 2031 | Dec 31, 2022 |
| N•••••• Life sciences · grade B | unattributed | 1 | at least $1.6M | 100c | n/a | Dec 31, 2028 | Dec 31, 2023 |
| C••••• M•••••• Life sciences | Sponsor not establishedpossible: S••••••••• C•••••• L• (a company of this name is on the sponsor's portfolio page) | 1 | at least $1.5M | 101c | n/a | Oct 31, 2028 | Jun 30, 2023 |
| M•••••• Life sciences · grade B | unattributed | 1 | at least $1.5M | 100c | n/a | May 10, 2028 | Dec 31, 2022 |
| R•••••• I•• Life sciences | unattributed | 5 | at least $1.4M | 100c | n/a | Apr 18, 2031 | Dec 31, 2021 |
| S••••• Life sciences · grade B | unattributed | 1 | at least $1.4M | 66c | n/a | Dec 22, 2027 | Dec 31, 2022 |
| H••••••••• Life sciences | Sponsor not establishedpossible: R•••••••• P•••••••• L•• (a company of this name is on the sponsor's portfolio page) | 2 | at least $1.1M | 100c | n/a | Aug 20, 2029 | Mar 31, 2023 |
| C••••••• p•• Life sciences | unattributed | 1 | at least $951,000 | 101c | n/a | Jun 3, 2033 | Dec 31, 2024 |
| G•••••• I••••••••• S••••••• D••••••••• A••••••• C•••••• Life sciences | unattributed | 2 | at least $720,000 | 101c | n/a | Apr 14, 2033 | Jun 30, 2026 |
| R•• • M•••••• Life sciences | unattributed | 1 | at least $660,089 | 97c | n/a | Feb 4, 2028 | Dec 31, 2022 |
| C••••••• Life sciences | unattributed | 2 | at least $622,939 | 101c | n/a | Aug 30, 2030 | Mar 31, 2022 |
| V•••• Life sciences · grade B | unattributed | 1 | at least $546,820 | 95c | n/a | Oct 29, 2031 | Dec 31, 2024 |
| H••••••••• L•••• S•••••• G•••• Life sciences | unattributed | 1 | at least $446,195 | 100c | n/a | Feb 2, 2033 | Mar 31, 2026 |
| I•••• I•• Life sciences | unattributed | 4 | at least $244,000 | 100c | n/a | Jan 2, 2031 | Dec 31, 2023 |
| A••• I•• I•••••••• I• Life sciences | unattributed | 1 | unknown | n/a | n/a | unstated | Jun 30, 2024 |
| A••••• H••••• S•••• Life sciences · grade B | unattributed | 3 | unknown | n/a | n/a | unstated | Jun 30, 2023 |
| C• T•••• H•••••••• I•• Life sciences | unattributed | 1 | unknown | n/a | n/a | unstated | Dec 31, 2021 |
| D•••••••• M•• H••••• L•• Life sciences | unattributed | 1 | unknown | n/a | n/a | unstated | Jun 30, 2024 |
| E•• P•••••• L•• Life sciences | unattributed | 2 | unknown | n/a | n/a | unstated | Dec 31, 2021 |
| P••••••••• Life sciences | unattributed | 1 | unknown | n/a | n/a | Dec 31, 2026 | Dec 31, 2025 |
| S•• H••••• L•• Life sciences | unattributed | 2 | unknown | n/a | n/a | unstated | Dec 31, 2023 |
| V••••• D••••••••• H••••••• L•• Life sciences | unattributed | 1 | unknown | n/a | n/a | unstated | Jun 30, 2025 |
Page 2 of 2Previous
The borrower, lender and sponsor names past the first 3 rows are hidden. Open a row to reveal that record with a free account (5 a month), or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source is public either way.